These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3414087)

  • 1. [Clinico-therapeutic and microbiological research on the preparation Monaspor in patients with active pyelonephritis].
    Todorova L; Stefanov G; Dimitrov Ts; Anastasov G; Tishkov I
    Vutr Boles; 1988; 27(1):68-72. PubMed ID: 3414087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug sensitivity of urinary microflora and the effect of treatment in exacerbated chronic pyelonephritis].
    Robeva R; Gruev I; Vasilev T; Neshev Kh
    Vutr Boles; 1986; 25(3):68-74. PubMed ID: 3765581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-therapeutic and microbiologic studies of the Bulgarian antibiotic cephalothin in patients with active pyelonephritis].
    Astrug A; Gavrilov G; Todorova L; Lobutova M; Tsenova Z
    Vutr Boles; 1983; 22(6):62-9. PubMed ID: 6369792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microbiologic indices of the urine in patients with various courses of pyelonephritis].
    Rudenko AV; Maĭdannik VG; Pilipenko VN
    Vrach Delo; 1989 Aug; (8):50-2. PubMed ID: 2588529
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinico-laboratory evaluation of the efficacy of Ciprobai and Cifran in treating the exacerbations of chronic pyelonephritis in patients with urolithiasis].
    Savitskaia KI; Trapeznikova MF; Dutov VV; Nekhorosheva AG; Nasonov VN; Skala LZ
    Urol Nefrol (Mosk); 1994; (3):11-4. PubMed ID: 8079401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of urologic infections with cefamandole (Pharmachim)--the microbiological and clinical results].
    Minkov N; Zlatanov Z; Zozikov B; Khristova D
    Vutr Boles; 1986; 25(4):32-8. PubMed ID: 3765588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microbial spectrum in chronic pyelonephritis and the drug sensitivity of the microorganisms].
    Gruev I; Lobutova M; Markova B; Neshev Kh; Robeva R
    Vutr Boles; 1985; 24(3):33-8. PubMed ID: 4024620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct bacteriological studies of patients with calculous pyelonephritis].
    Anastasov G; Todorova L; Panchev P; Raĭchev G
    Vutr Boles; 1985; 24(6):94-100. PubMed ID: 4095985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Our experience of treating urological infections with a single dose of gentamycin].
    Belovezhdov N; Angelova I; Stefanov G; Stoianova M; Chakŭrski I
    Vutr Boles; 1988; 27(2):101-3. PubMed ID: 3414092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical trial of pefloxacin (Abaktal) in the treatment of acute pyelonephritis].
    Gorski J; Wehnert J; Lange D; Koch H; Wichmann G
    Z Urol Nephrol; 1990 Feb; 83(2):55-60. PubMed ID: 2195800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria.
    Suankratay C; Jutivorakool K; Jirajariyavej S
    J Med Assoc Thai; 2008 Aug; 91(8):1172-81. PubMed ID: 18788687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of lower urinary tract infections and pyelonephritis in children.
    Bensman A; Ulinski T
    Expert Opin Pharmacother; 2009 Sep; 10(13):2075-80. PubMed ID: 19663608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of urinary infection with cephadroxyl (Pharmachem)--microbiological and clinical research].
    Minkov N; Zlatanov Z; Zozikov B; Khristova D
    Vutr Boles; 1987; 26(5):98-104. PubMed ID: 3433735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
    Piccolomini R; Ravagnan G
    Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of pyelonephritis. 800 quantitative bacteria determination].
    Siegel C
    Med Klin; 1966 Sep; 61(39):1537-42. PubMed ID: 4873696
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of antibiotic therapy in pyelonephritis after kidney transplantation].
    Vasina TA; Kutasova IV; Lobanova ED
    Antibiotiki; 1981 Apr; 26(4):311-5. PubMed ID: 7016024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation by immunofluorescence of the urinary bacteria, of the therapy effectiveness in urinary infections.
    Gluhovschi G; Drăgan I; Arcan P; Bendea R
    Med Interne; 1990; 28(4):279-88. PubMed ID: 2100873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of piperacillin in the urological field].
    Hayashida S; Kitajima K; Joko K
    Hinyokika Kiyo; 1983 Apr; 29(4):465-76. PubMed ID: 6563846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.